All Eyes on ExPEC: A Major Driver of Invasive Disease and Antimicrobial Resistance

Download All
Hear from experts on the burden of extraintestinal pathogenic E coli (ExPEC), risk factors for invasive disease and multidrug resistance, and the evolving vaccine landscape for ExPEC prevention during the live symposia. Reinforce your learning with an on-demand video, downloadable slides, podcast, and expert-authored commentaries highlighting key discussion points about ExPEC.
Lilian Abbo Headshot
Lilian Abbo, MD, FIDSA
person default
Julie Ann Justo, PharmD, MS
David Van Duin, MD, PhD, FIDSA, FAST


Here’s my summary of our current knowledge about extraintestinal pathogenic Escherichia coli and the challenges and opportunities associated with vaccine development for these bacteria.

person default Julie Ann Justo, PharmD, MS Released: August 31, 2022

Preventive measures such as vaccination are strong antimicrobial stewardship tools that need more development so the attention is not focused only on the development of new antibiotics. Here are my thoughts on the current landscape of vaccines against extraintestinal pathogenic Escherichia coli.

Lilian Abbo Headshot Lilian Abbo, MD, FIDSA Released: October 6, 2022

Extraintestinal pathogenic E coli (ExPEC) has been around for a long time and will likely remain clinically important in the foreseeable future. Read Dr David van Duin’s thoughts on why this is a concern and what populations are at highest risk for developing ExPEC invasive infections.

David Van Duin, MD, PhD, FIDSA, FAST Released: December 6, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings